Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Nitric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA5A | P35218 | 1/20 | 0.80 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.80 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.33 |
| ▸ | TSHR | P16473 | 3/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Nitric Acid SCHEMBL2466156 | 1.00 | CA5A (0.80) | CA5ACA5BMEN1KMT2AALDH1A1 | |
| Nitric Acid SCHEMBL10339100 | 1.00 | — | — | |
| Nitric Acid SCHEMBL218219 | 1.00 | — | — | |
| Nitric Acid SCHEMBL7126708 | 1.00 | — | — | |
| Nitric Acid SCHEMBL94578 | 1.00 | CA5A (0.80) | CA5ACA5BMEN1KMT2AALDH1A1 | |
| Nitric Acid SCHEMBL9162752 | 1.00 | — | — | |
| Nitric Acid SCHEMBL4014809 | 1.00 | CA5A (0.80) | CA5ACA5BMEN1KMT2AALDH1A1 | |
| Nitric Acid SCHEMBL407617 | 1.00 | CA5A (0.80) | CA5ACA5BMEN1KMT2AALDH1A1 | |
| Nitric Acid SCHEMBL8982116 | 0.95 | — | — | |
| Nitric Acid SCHEMBL8982097 | 0.95 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11631565-B2 | Thermal fuse | SCIENCE APPLICATIONS INTERNATIONAL CORPORATION (US) | 2023-04-18 | — | — | US | disclosed |
| US-20220165529-A1 | Thermal Fuse | CITIBANK, N.A., AS COLLATERAL AGENT | 2022-05-26 | — | — | US | disclosed |
| CN-112011314-A | Composite phase-change material for hot water supply heat accumulator and preparation method thereof | 河南百川畅银环保能源股份有限公司 | 2020-12-01 | — | — | CN | disclosed |
| CN-109852392-B | Composition for repairing contaminated soil of relocation site of electroplating enterprise and application thereof | 中国科学院南京土壤研究所 | 2020-08-25 | — | — | CN | disclosed |
| EP-2940004-B1 | METHOD FOR PRODUCING OXIME | SUMITOMO CHEMICAL CO (JP) | 2017-09-13 | — | — | EP | disclosed |
| US-9533944-B2 | Method for producing oxime | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2017-01-03 | — | — | US | disclosed |
| US-20150353478-A1 | METHOD FOR PRODUCING OXIME | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2015-12-10 | — | — | US | disclosed |
| EP-2940004-A1 | METHOD FOR PRODUCING OXIME | Sumitomo Chemical Company Limited (JP) | 2015-11-04 | — | — | EP | disclosed |
| US-6670037-B1 | Coating agent consisting of delta-alumina or pseudoboehmite dispersed and aluminum nitrate nonahydrate dissolved in aqueous dispersing medium, and binder | TAIHO INDUSTRIES CO., LTD. (JP) | 2003-12-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150353478-A1 | METHOD FOR PRODUCING OXIME | HAO2, HMOX2, OXGR1 | CA5A 452/4885CA5B 417/4885MEN1 1091/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.